Your browser doesn't support javascript.
loading
Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire.
Pollastro, Sabrina; Klarenbeek, Paul L; Doorenspleet, Marieke E; van Schaik, Barbera D C; Esveldt, Rebecca E E; Thurlings, Rogier M; Boumans, Maria J H; Gerlag, Danielle M; Tak, Paul P; Vos, Koen; Baas, Frank; van Kampen, Antoine H C; de Vries, Niek.
Afiliação
  • Pollastro S; Amsterdam Rheumatology and Immunology Center (ARC) | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Klarenbeek PL; Department of Experimental Immunology | Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Doorenspleet ME; Amsterdam Rheumatology and Immunology Center (ARC) | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van Schaik BDC; Amsterdam Rheumatology and Immunology Center (ARC) | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Esveldt REE; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam Public Health Research Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Thurlings RM; Amsterdam Rheumatology and Immunology Center (ARC) | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Boumans MJH; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gerlag DM; Amsterdam Rheumatology and Immunology Center (ARC) | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Tak PP; Amsterdam Rheumatology and Immunology Center (ARC) | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Vos K; Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, UK.
  • Baas F; Amsterdam Rheumatology and Immunology Center (ARC) | Department of Clinical Immunology and Rheumatology, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van Kampen AHC; Department of Medicine, Cambridge University, Cambridge, Massachusetts, USA.
  • de Vries N; Department of Rheumatology, Ghent University, Ghent, Belgium.
Ann Rheum Dis ; 78(10): 1339-1345, 2019 10.
Article em En | MEDLINE | ID: mdl-31217169
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Linfócitos B / Receptores de Antígenos de Linfócitos B / Antirreumáticos / Rituximab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Linfócitos B / Receptores de Antígenos de Linfócitos B / Antirreumáticos / Rituximab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article